Maryland Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,094
Closed -$232K 248
2021
Q4
$232K Buy
5,094
+584
+13% +$30.5K 0.01% 243
2021
Q3
$286K Buy
4,510
+68
+2% +$5.18K 0.02% 211
2021
Q2
$407K Sell
4,442
-979
-18% -$77.8K 0.02% 181
2021
Q1
$369K Buy
+5,421
New +$421K 0.02% 180

Other funds holding CDNA

Maryland Capital Management's CDNA Position: Q1 2022 in Review

Maryland Capital Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 5,094 shares — an estimated $232K sold.

Maryland Capital Management first reported a position in CDNA in Q1 2021 and held it in 4 quarters. The position peaked at $407K in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Maryland Capital Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Maryland Capital Management sold 5,094 CareDx shares in Q1 2022, an estimated $232K.
  • Maryland Capital Management first reported a position in CareDx in Q1 2021 and held it in 4 quarters.
  • Maryland Capital Management's CareDx position peaked at $407K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Maryland Capital Management's 13F filing for Q1 2022, filed 12 May 2022.